🇺🇸 FDA
Patent

US 11124787

ADAMTS13-containing compositions having thrombolytic activity

granted A61KA61K38/17A61K38/4886

Quick answer

US patent 11124787 (ADAMTS13-containing compositions having thrombolytic activity) held by Takeda Pharmaceutical Company Limited expires Mon Sep 16 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Takeda Pharmaceutical Company Limited
Grant date
Tue Sep 21 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 16 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
17
CPC classes
A61K, A61K38/17, A61K38/4886, A61P, A61P7/02